Samuel Zagarella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Samuel Zagarella has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Michael Bigby
Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts
5 shared publicationsCatalin Popescu
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
4 shared publications- Michael J. Sladden
University of Tasmania Launceston Tasmania Australia
4 shared publications Michael Sladden
Department of Medicine, University of Tasmania Medical School, Launceston, Tasmania, Australia
3 shared publicationsC. Popescu
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2 shared publicationsGayle Fischer
Royal North Shore Hospital
2 shared publications
Latest Publications
- Open Access
- 8 July 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (6) , e365-e368
Zosteriform Primary Cutaneous Marginal Zone Lymphoma—A Case Report
We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.
- 8 July 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (6) , e365-e368
Open AccessZosteriform Primary Cutaneous Marginal Zone Lymphoma—A Case Report
We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.
- 1 January 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 88 (1) , e27-231
Letter to the editor
- 1 January 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 88 (1) , e27-231
Letter to the editor
- 2 December 2021
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (1) , 120-121
Successful treatment of pityriasis rubra pilaris with tildrakizumab
- 2 December 2021
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (1) , 120-121
Successful treatment of pityriasis rubra pilaris with tildrakizumab
- 24 May 2021
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 62 (3) , E471-E473
Vesiculobullous Hailey–Hailey’s disease with scarring mimicking a subepidermal autoimmune blistering disease and its management with retinoids
- 24 May 2021
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 62 (3) , E471-E473
Vesiculobullous Hailey–Hailey’s disease with scarring mimicking a subepidermal autoimmune blistering disease and its management with retinoids
- 25 June 2020
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (4) , E421-E423
Eosinophilic cellulitis successfully treated with Methotrexate
Eosinophilic cellulitis is a rare inflammatory skin disease of unknown aetiology, first described by George Wells in 1971 as a recurrent granulomatous dermatitis with eosinophilia. It is typically characterised by recurrent pruritic erythematous plaques, vesicles or bullae usually involving the extremities and trunk. Many cases of eosinophilic cellulitis are difficult to treat and traditionally require long course of oral steroids, resulting in steroid side effects. This case adds to the literature in that we report the use of methotrexate to treat eosinophilic cellulitis, as a safe and efficacious therapeutic alternative.
- 25 June 2020
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (4) , E421-E423
Eosinophilic cellulitis successfully treated with Methotrexate
Eosinophilic cellulitis is a rare inflammatory skin disease of unknown aetiology, first described by George Wells in 1971 as a recurrent granulomatous dermatitis with eosinophilia. It is typically characterised by recurrent pruritic erythematous plaques, vesicles or bullae usually involving the extremities and trunk. Many cases of eosinophilic cellulitis are difficult to treat and traditionally require long course of oral steroids, resulting in steroid side effects. This case adds to the literature in that we report the use of methotrexate to treat eosinophilic cellulitis, as a safe and efficacious therapeutic alternative.
- 22 June 2020
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (4) , E451-E452
Peristomal morphoea in a patient with systemic sclerosis
- 22 June 2020
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (4) , E451-E452
Peristomal morphoea in a patient with systemic sclerosis
- 19 September 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 182 (2) , 518
The sentinel node biopsy has not come of age
- 19 September 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 182 (2) , 518
The sentinel node biopsy has not come of age
- 20 April 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 59 (4) , 286-290
Nerve entrapment syndromes in dermatology: Review and practical approach to treatment
A good understanding of cutaneous nerve entrapment syndromes is important for physicians to provide early and accurate diagnosis and treatment. These syndromes have traditionally been managed with analgesics, antidepressants or antiepileptic medication but this approach is often inadequate and causes frequent adverse medication effects. With early diagnosis and treatment, many nerve entrapment syndromes can be successfully managed with physical, non‐pharmacological approaches including stretches, exercises and physiotherapy.
- 20 April 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 59 (4) , 286-290
Nerve entrapment syndromes in dermatology: Review and practical approach to treatment
A good understanding of cutaneous nerve entrapment syndromes is important for physicians to provide early and accurate diagnosis and treatment. These syndromes have traditionally been managed with analgesics, antidepressants or antiepileptic medication but this approach is often inadequate and causes frequent adverse medication effects. With early diagnosis and treatment, many nerve entrapment syndromes can be successfully managed with physical, non‐pharmacological approaches including stretches, exercises and physiotherapy.
- 7 February 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 59 (2) , 159-160
When is a sentinel node biopsy indicated for patients with primary melanoma? Comment on the ‘Australian guidelines for the management of cutaneous melanoma’
- 7 February 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 59 (2) , 159-160
When is a sentinel node biopsy indicated for patients with primary melanoma? Comment on the ‘Australian guidelines for the management of cutaneous melanoma’
- 7 February 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 59 (2) , 160-161
‘Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal’ by Omgo E Nieweg, Alan Cooper and John F Thompson
- 7 February 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 59 (2) , 160-161
‘Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal’ by Omgo E Nieweg, Alan Cooper and John F Thompson